Lupin announced today that Health Canada has approved Rymti its biosimilar to Enbrel etanercept for use in Canada Rymti is indicated in the treatment of rheumatoid arthritis juvenile idiopathic arthritis psoriatic arthritis axial spondyloarthritis including ankylosing spondylitis and non-radiographic axial spondyloarthritis plaque psoriasis and paediatric plaque psoriasis
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
